MARKETSNeostem (NBS) Stock Declines After Pricing Secondary Public OfferingBy Tony OwusuMay 28, 2015 12:59 PM EDT
STOCKSFifteen Fabulously Intelligent Biotech Stock Predictions for 2015By Adam FeuersteinJan 6, 2015 11:52 AM EST
MARKETSInsider Trading Alert - UGI, NBS And MACK Traded By InsidersBy James Giaquinto Dec 5, 2014 11:15 AM EST
MARKETSNeoStem (NBS) Stock Plummets Today on Disappointing Cardiac Stem-Cell Therapy DataBy Andrew MeolaNov 18, 2014 12:40 PM EST
INVESTINGNeoStem's Stem Cell Therapy Fails Mid-Stage Heart Attack StudyBy Adam FeuersteinNov 18, 2014 10:16 AM EST
STOCKSSuper Important Biotech and Drug Stock Events for NovemberBy Adam FeuersteinNov 3, 2014 8:24 AM EST
STOCKSBiotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech EventsBy Adam FeuersteinJul 14, 2014 9:30 AM EDT
STOCKSBiotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech EarningsBy Adam FeuersteinApr 17, 2014 9:18 AM EDT
OPINIONSpeculative Money Propels Biotechs La Jolla Pharma, Aeterna ZentarisBy Ciaran ThorntonMar 11, 2014 4:31 PM EDT
